ABT vs PPTA · P/E 25, rev $44.33B vs $3.11B cap
Abbott Laboratories (ABT) versus Perpetua Resources Corp (PPTA) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Perpetua Resources Corp (PPTA) is a other precious metals & mining company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
PPTA does not have a complete income-statement cache yet.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. PPTA currently screens at market cap $3.11B.
Not investment advice. Open the ABT and PPTA stock pages for the full models.
Not investment advice.